Post-diagnostic use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of prostate cancer-specific mortality

Autoria(s): McMenamin, Úna; Murray, Liam; Hughes, Carmel; Cantwell, Marie; Cardwell, Christopher
Data(s)

29/11/2013
Identificador

http://pure.qub.ac.uk/portal/en/publications/postdiagnostic-use-of-angiotensinconverting-enzyme-inhibitors-and-angiotensin-receptor-blockers-and-risk-of-prostate-cancerspecific-mortality(5af8fb59-4f05-49f2-b94e-cdc8e32c5804).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

McMenamin , Ú , Murray , L , Hughes , C , Cantwell , M & Cardwell , C 2013 , ' Post-diagnostic use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of prostate cancer-specific mortality ' UKCRC Centre of Excellence for Public Health Away Day 2013 , United Kingdom , 29/11/2013 - 29/11/2013 , .
Tipo

conferenceObject
Acesso ao item digital